UniProtKB/Swiss-Prot Q496J9: Variant p.Asp543Asn

Synaptic vesicle glycoprotein 2C
Gene: SV2C
Feedback?

Variant information Variant position:

543 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Aspartate (D) to Asparagine (N) at position 543 (D543N, p.Asp543Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and acidic (D) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs31244 [ dbSNP | Ensembl ]

Sequence information Variant position:

543 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

727 The length of the canonical sequence.
Location on the sequence:

EDVTSVNTYFKNCTFIDTVF D NTDFEPYKFIDSEFKNCSFF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         EDVTSVNTYFKNCTFIDTVFDNTDFEPYKFIDSEFKNCSFF

Mouse                         DDVTSVNTYFKNCTFIDTLFDNTDFEPYKFIDSEFQNCSFL

Rat                           DDVTSVNTYFKNCTFIDTLFENTDFEPYKFIDSEFQNCSFL

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 727	Synaptic vesicle glycoprotein 2C
Topological domain	459 – 578	Extracellular
Region	519 – 563	(Microbial infection) C.botulinum neurotoxin type A-binding
Glycosylation	534 – 534	N-linked (GlcNAc...) asparagine
Glycosylation	559 – 559	N-linked (GlcNAc...) asparagine
Mutagenesis	559 – 559	N -> A. No change in interaction with C.botulinum neurotoxin type A heavy chain (botA, BoNT/A HC). Decreased molecular weight probably due to glycosylation loss, decreased interaction with BoNT/A HC.
Mutagenesis	559 – 559	N -> Q. Decreased molecular weight probably due to glycosylation loss, decreased binding to BoNT/A HC. Greater reduction in weight; when associated with Q-565.
Mutagenesis	561 – 561	S -> A. Decreased molecular weight probably due to glycosylation loss, decreased binding to BoNT/A HC.
Mutagenesis	563 – 563	F -> A. No longer interacts with BoNT/A HC.
Beta strand	541 – 544

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.